UA113236U - PHARMACEUTICAL FIXED COMBINATION WITH ANALYSIS AND SODIUM OR SOFTING EFFECTS BASED ON Meloxicam - Google Patents
PHARMACEUTICAL FIXED COMBINATION WITH ANALYSIS AND SODIUM OR SOFTING EFFECTS BASED ON MeloxicamInfo
- Publication number
- UA113236U UA113236U UAU201605811U UAU201605811U UA113236U UA 113236 U UA113236 U UA 113236U UA U201605811 U UAU201605811 U UA U201605811U UA U201605811 U UAU201605811 U UA U201605811U UA 113236 U UA113236 U UA 113236U
- Authority
- UA
- Ukraine
- Prior art keywords
- meloxicam
- softing
- sodium
- analysis
- fixed combination
- Prior art date
Links
- ZRVUJXDFFKFLMG-UHFFFAOYSA-N Meloxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=NC=C(C)S1 ZRVUJXDFFKFLMG-UHFFFAOYSA-N 0.000 title abstract 2
- 229960001929 meloxicam Drugs 0.000 title abstract 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 title 1
- 229910052708 sodium Inorganic materials 0.000 title 1
- 239000011734 sodium Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000003444 anaesthetic effect Effects 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000001914 calming effect Effects 0.000 abstract 1
- HCFDWZZGGLSKEP-UHFFFAOYSA-N doxylamine Chemical compound C=1C=CC=NC=1C(C)(OCCN(C)C)C1=CC=CC=C1 HCFDWZZGGLSKEP-UHFFFAOYSA-N 0.000 abstract 1
- 229960005178 doxylamine Drugs 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 239000008203 oral pharmaceutical composition Substances 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000932 sedative agent Substances 0.000 abstract 1
- 230000001624 sedative effect Effects 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Фармацевтична композиція для перорального споживання є комбінацією щонайменше двох активних компонентів в їхніх ефективних кількостях, в тому числі у вигляді фармацевтично прийнятних солей, сольватів, естерів, оптичних ізомерів та прекурсорів, які вивільняються негайно. Один з компонентів проявляє снодійний та/або заспокійливий ефект, а другий - знеболюючий ефект. Знеболювальним компонентом є мелоксикам, доза якого у композиції становить від 7,5 мг до 15 мг. Снодійним компонентом в композиції є доксиламін.An oral pharmaceutical composition is a combination of at least two active ingredients in their effective amounts, including in the form of pharmaceutically acceptable salts, solvates, esters, optical isomers and precursors, which are released immediately. One component has a sedative and / or calming effect and the other has an analgesic effect. The anesthetic component is meloxicam, the dose of which in the composition is from 7.5 mg to 15 mg. A doxylamine is a sleeping component in the composition.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201605811U UA113236U (en) | 2016-05-30 | 2016-05-30 | PHARMACEUTICAL FIXED COMBINATION WITH ANALYSIS AND SODIUM OR SOFTING EFFECTS BASED ON Meloxicam |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201605811U UA113236U (en) | 2016-05-30 | 2016-05-30 | PHARMACEUTICAL FIXED COMBINATION WITH ANALYSIS AND SODIUM OR SOFTING EFFECTS BASED ON Meloxicam |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA113236U true UA113236U (en) | 2017-01-25 |
Family
ID=58049776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201605811U UA113236U (en) | 2016-05-30 | 2016-05-30 | PHARMACEUTICAL FIXED COMBINATION WITH ANALYSIS AND SODIUM OR SOFTING EFFECTS BASED ON Meloxicam |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA113236U (en) |
-
2016
- 2016-05-30 UA UAU201605811U patent/UA113236U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX380767B (en) | METHODS TO REDUCE CARDIOVASCULAR RISK. | |
| CY1124052T1 (en) | ORALLY DISPERSIBLE TABLET CONTAINING ESTETROL | |
| MX2017000627A (en) | METHODS FOR TREATING PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (heFH). | |
| AR096892A1 (en) | A PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF MELANOMA | |
| BR112015023922A2 (en) | pharmaceutical composition comprising an ampk activator and a serotonergic agent and methods of using these | |
| DOP2016000156A (en) | PHARMACEUTICAL COMPOSITIONS THAT INCLUDE AZD9291. | |
| PE20160011A1 (en) | COMBINED NEOSAXITOXIN FORMULATIONS FOR PROLONGED LOCAL ANESTHESIA | |
| SV2017005595A (en) | ORODISPERSABLE DOSAGE UNIT CONTAINING A STETROL COMPONENT | |
| MX394857B (en) | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION INCLUDING ENZALUTAMIDE. | |
| BR112019002513A2 (en) | use and dosage of therapeutic agents for endometriosis | |
| MX2020004107A (en) | DELAYED RELEASE DEFERIPRONE TABLETS AND METHODS OF USE THEREOF. | |
| BR112014014795A2 (en) | immediate release multi-unit pellet system | |
| MX390667B (en) | DOSAGE AND REGIMEN FOR AN INHIBITOR OF HDM2-P53 INTERACTION IN HEMATOLOGICAL TUMORS. | |
| CL2021000882A1 (en) | Formulations and methods for treating chemotherapy-induced nausea and vomiting. | |
| CL2021002107A1 (en) | Triamterene or nolatrexed for use in the treatment of phenylketonuria. | |
| CL2019000753A1 (en) | Pharmaceutical composition comprising mineralocorticoid receptor antagonist and its use. | |
| BR112018073419A2 (en) | combination, use of combination, method for treatment, compound, method for treatment of alzheimer's disease and pharmaceutical composition | |
| BR112018073410A2 (en) | antagonist combination, use of the combination, method of treatment, compound, method for the treatment of alzheimer's disease and pharmaceutical composition | |
| BR112019017314A2 (en) | pharmaceutical compositions for combination therapy | |
| MX386521B (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING A MUSCLE RELAXANT AND A NON-STEROIDAL ANTI-INFLAMMATORY (NSAID). | |
| UA113236U (en) | PHARMACEUTICAL FIXED COMBINATION WITH ANALYSIS AND SODIUM OR SOFTING EFFECTS BASED ON Meloxicam | |
| MX387263B (en) | PROLONGED-RELEASE PHARMACEUTICAL COMPOSITION COMPRISING CYSTEAMINE OR SALT THEREOF. | |
| CO2018013792A2 (en) | Dosing regimens of vortioxetine for the rapid onset of the antidepressant effect | |
| MX2017013633A (en) | Tamper-resistant fixed dose combination providing fast release of two drugs from particles. | |
| MX381450B (en) | A combination medicine comprising phenylephrine and paracetamol |